Ranbaxy Laboratories has set up a new manufacturing facility in South
Africa.
The new unit has been set up at an investment of $30 million (approx Rs
139.5 crore). It has the capacity to produce approximately 1.75 billion units
per annum and packaging of two billion units per annum of drugs.
The plant manufactures analgesics, cold, cough and flu
preparations, anti-histamines, anti-hypertensive, central nervous system
drugs, vitamins and minerals as well as a comprehensive range of
over-the-counter medication. The products manufactured are to comprise tablets
and hard gelatin capsules which are likely to be supplied to current
registered regions.
The company's new facility is the second manufacturing unit in South Africa
and the third in the African continent after Nigeria.